ALTUVIIIO™ approved by the U.S. FDA: this positive event triggers impairment reversal, positively impacting 2022 IFRS net income; no change on business net income (non-IFRS)
FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection. This positive event triggers impairment reversal, impacting 2022 IFRS net income; no change on business net income (non-IFRS)
Filing of the 2022 U.S. Form 20-F and French “Document d’EnregistrementUniversel” containing the Annual Financial Report
Paris, February 24, 2023. Sanofi announces today the filing of its Form 20-F with the U.S. Securities and Exchange Commission (SEC) and its “Document d’Enregistrement Universel” containing its Annual Financial Report with the French market regulator Autorité des marchés financiers (AMF).
On February 22, 2023, the US Food and Drug Administration (FDA) approved ALTUVIIIOTM. This confirms the significant increase of value of the asset. That decision, which occurred prior to the filing of the French Document d’enregistrement universel and of the Annual Report on Form 20-F, resulted in an adjustment to IFRS net income for the year ended December 31, 2022 as presented in the Sanofi press release issued on February 3, 2023. The adjustment consisted of the reversal of €2,154 million of impairment losses against the intangible assets associated with the Eloctate franchise, in accordance with IAS 36 (Impairment of Assets); the assets had been partially written down in 2019. The adjustment is presented within the line item Impairment of intangible assets in the consolidated income statement; the net impact after tax is a gain of €1,651 million. Cash flows are not impacted by the adjustment. Following the adjustment, for the year ended December 31, 2022, IFRS net income amounts to €8,371 million (versus €6,720 million as per the press release of February 3, 2023); earnings per share (IFRS EPS) amounts to €6.69 (versus €5.37 as per the press release of February 3, 2023); and total equity amounts to €75,152 million (versus €73,512 million as per the press release of February 3, 2023).
Business net income (a non-IFRS financial measure) for the year ended December 31, 2022 is unchanged, as is the amount of the dividend proposed by the Board of Directors held on February 2, 2023.
Updated IFRS figures for 2022 Financial Statements1
|Q4 2022||Change||Change |
|IFRS net sales reported||€10,725m||+7.3%||+2.6%||€42,997m||+13.9%||+7.0%|
|IFRS net income reported||€3,111m||+175.1%||_||€8,371m||+34.5%||—|
|IFRS EPS reported||€2.48||+175.9%||_||€6.69||+34.6%||—|
|Free cash flow(2)||€2,546m||+0.2%||_||€8,483m||+4.8%||—|
|Business operating income||€2,724m||+20.7%||+15.0%||€13,040m||+21.7%||+13.3%|
|Business net income(1)||€2,141m||+23.8%||+17.6%||€10,341m||+25.9%||+17.0%|
Changes in net sales are expressed at constant exchange rates (CER) unless otherwise indicated (definition in Appendix 9 of February 3, 2023 Press Release). (1) In order to facilitate an understanding of operational performance, Sanofi comments on the business net income statement. Business net income is a non-IFRS financial measure (definition in Appendix 9 of February 3, 2023 Press Release). The reconciliation of reported IFRS net income to business net income is set forth in the 2022 U.S. Form 20-F page 62 and French “Document d’EnregistrementUniversel” page 142; (2) Free cash flow is a non-IFRS financial measure (definition in Appendix 9 of February 3, 2023 Press Release).
These documents are available on the company’s website: https://www.sanofi.com/en/investors/reports-and-publications/financial-and-csr-reports.
In addition, the Form 20-F is available on the website of the SEC (www.sec.gov) and the “Document d’Enregistrement Universel” is available on the website of the AMF (www.amf-france.org). A hard copy of these documents, each of which contains our complete audited financial statements, may be received free of charge, upon request.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Sandrine Guendoul | + 33 6 25 09 14 25 | firstname.lastname@example.org
Victor Rouault | + 33 6 70 93 71 40 | email@example.com
Evan Berland | +1 215 432 0234 | firstname.lastname@example.org
Kate Conway | + 1 508 364 4931 | email@example.com
Eva Schaefer-Jansen | + 33 7 86 80 56 39 | firstname.lastname@example.org
Arnaud Delépine| + 33 6 73 69 36 93 | email@example.com
Corentine Driancourt | + 33 6 40 56 92 21 | firstname.lastname@example.org
Felix Lauscher | + 1 908 612 7239 | email@example.com
Tarik Elgoutni| + 1 617 710 3587 | firstname.lastname@example.org
Nathalie Pham | + 33 7 85 93 30 17 | email@example.com
- Updated vs. February 3, 2023 press release
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Classic Parade announces its incorporation as an LTD company27.3.2023 16:36:04 CEST | Press release
LONDON, March 27, 2023 (GLOBE NEWSWIRE) -- After 20 years under family ownership, Classic Parade, a hypercar hire company in London, will now effective immediately become an LTD company that has financial backing from Qatari investors. This move comes from a strategic business decision to focus on growth beyond the United Kingdom. Currently, Classic Parade services luxury hypercar hire customers all over the UK, but with the revitalizing investment from its new owners, it aims to become the premium hypercar hire company that services all of Europe. No other luxury supercar for-hire provider serves that large of a geographical location in the area; Classic Parade will be the first. Its existing portfolio of vehicles is vast, including well-known brands in the luxury vehicle community such as Ferrari, McLaren, Rolls Royce, Porsche, Audi, and more. A hire agreement can be completed in as little as 24 hours, making it possible to get a next-day hypercar hire in the UK. With these same serv
Kallelse till årsstämma i Bilia AB27.3.2023 16:30:00 CEST | Pressemelding
Aktieägarna i Bilia AB, org.nr. 556112-5690, kallas till årsstämma onsdagen den 26 april 2023 klockan 14:00 på Haga Norra, Torfredsplatsen 1. Inregistrering börjar kl. 13:00. Styrelsen har beslutat att aktieägare ska kunna utöva sin rösträtt på årsstämman även genom poströstning i enlighet med föreskrifterna i Bilia AB:s bolagsordning. Förutsättningar för deltagande A. Aktieägare som önskar delta i årsstämman genom poströstning ska dels vara registrerad i den av Euroclear Sweden AB förda aktieboken avseende förhållandena den 18 april 2023,dels anmäla sig genom att avge sin poströst enligt anvisningar under rubriken Poströstning nedan så att poströsten är Computershare AB tillhanda senast den 20 april 2023. B. Aktieägare som önskar närvara i stämmolokalen personligen eller genom ombud ska dels vara registrerad i den av Euroclear Sweden AB förda aktieboken avseende förhållandena den 18 april 2023,dels anmäla sig hos bolaget senast den 20 april 2023 under adress Computershare AB, ”Bilia A
Notice of the Annual General Meeting in Bilia AB27.3.2023 16:30:00 CEST | Press release
The shareholders of Bilia AB, org.no. 556112-5690, are hereby given notice of the Annual General Meeting (“AGM”) to be held on Wednesday 26 April 2023 at 14:00 at Haga Norra, Torfredsplatsen 1, Solna. Registration for the AGM will commence at 13:00. The Board of Directors has decided that the shareholders shall be able to exercise their voting rights by postal voting in accordance with the company´s articles of association. Preconditions for participation A. Shareholders who wish to participate at the AGM by postal voting must: be recorded in the shareholders’ register kept by Euroclear Sweden AB as per 18 April 2023,and must notify its intention to participate by casting its postal vote in accordance with the instructions under the heading “Postal voting” so that the postal vote is received by the company through Computershare AB no later than 20 April 2023. B. Shareholders who wish to participate at the AGM in person or by proxy must: be recorded in the shareholders’ register kept by
Monument Commences Mining High Grade Sulphide Ore at Selinsing Gold Mine27.3.2023 16:28:27 CEST | Press release
VANCOUVER, British Columbia, March 27, 2023 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) ("Monument" or the "Company") is pleased to update the progress at the Selinsing Sulphide Project with the commencement of mining high grade sulphide ores from Buffalo Reef at the Selinsing Gold Mine in Malaysia. New mining equipment has been mobilized to increase mining production rates to meet commercial production rates through the soon to be commissioned sulphide treatment plant which is nearing nameplate capacity in readiness for gold concentrate sales. President and CEO Cathy Zhai commented, “The mining team have been undertaking pre-stripping activities at the Buffalo Reef area since July 2022 and has now recently exposed significant areas of sulphide ores. These higher-grade fresh ore zones will provide ample feed to enable the new processing plant to reach full production capacity in the coming weeks, and will allow the revenue stream from concentrate sales to com
Management's or Related parties' trading with SP Group A/S shares27.3.2023 16:28:01 CEST | Press release
Today, Schur Finance a/s, related parties to Chairman Hans W. Schur (Hans W. Schur is Managing Director of Schur Finance a/s), has acquired 5,000 number of SPG shares, ID Code DK0061027356, at a price of DKK 240.00 equal to DKK 1,200,000.00 and Today, Chief Executive Officer, Frank Gad, has acquired 6,000 number of SPG shares, ID Code DK0061027356, at a price of DKK 238,39 equal to DKK 1,430,365,80. Attachment Meddelelse nr. 17 - Insider Trading - ENG - 27 03 23